Login
$JNJ
$267.65 +$1.35 (0.51%) Live

$JNJ 8-K/A SEC Filings

Filed On Filing
22 Jan 2025 8-K/A: Financial Statements and Exhibits

New Brunswick, N.J. (January 22, 2025) – Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024. "2024 was a transformative year for Johnson & Johnson, marked by strong growth, an accelerating pipelin...

16 Apr 2024 8-K/A: Financial Statements and Exhibits

New Brunswick, N.J. (April 16, 2024) – Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2024. “Johnson & Johnson’s solid first quarter performance reflects our sharpened focus and the progress in our portfolio and ...

15 Feb 2023 8-K/A: Departure/Election of Directors or Officers; Compensation

Johnson & Johnson Names Paula A. Johnson, President of Wellesley College, to its Board of Directors New Brunswick, NJ (February 14, 2023) – Johnson & Johnson (NYSE: JNJ) announced today that Paula A. Johnson, MD, MPH, President of Welles...

29 Aug 2017 8-K/A: Completion of Acquisition or Disposition of Assets
04 Aug 2008 8-K/A: Results of Operations and Financial Condition
30 Nov 2007 8-K/A: Material Impairments; Other Events
02 Mar 2007 8-K/A: Completion of Acquisition or Disposition of Assets
30 Apr 2002 8-K/A: Other Events
30 Nov 2001 8-K/A: Other Events

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support